Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines

Anne S. Boewe(Saarland University), Claudia Götz(Saarland University)
Molecules
March 9, 2026
Cited by 0


Related Papers